CGRP-ANTAGONISTENPEPTIDE
European patent · EP3242882 · In force
Register entry
- Publication number
- EP3242882
- Application number
- EP16700059
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Jan 6, 2016
- Published
- Nov 15, 2017
- Granted
- May 4, 2022
- Protection ends at the latest
- Jan 5, 2036
- Next annual fee due
- Jan 31, 2027
- IPC classes
- C07D 513/04 (2006.01)C07K 7/64 (2006.01)A61K 38/12 (2006.01)A61P 25/06 (2006.01)
- Priority
- US 201562100371 P 06.01.2015
- PCT application
- PCT/EP2016/050110 06.01.2016
- PCT publication
- WO2016/110499 14.07.2016
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Feb 1, 2026
Change
Published in Swissreg on 01.02.2026
- Feb 1, 2025
Change
Published in Swissreg on 01.02.2025
- Feb 1, 2024
Change
Published in Swissreg on 01.02.2024
- Mar 15, 2023
Change
Published in Swissreg on 15.03.2023
- Feb 1, 2023
Change
Published in Swissreg on 01.02.2023
- May 4, 2022
Granted
Published in Swissreg on 04.05.2022
Parties
Inventor
SUEIRAS-DIAZ, Javier, J
La Jolla, California 92037-2315, US
JIANG, Guangcheng
San Diego, California 92130, US
WISNIEWSKI, Kazimierz
San Diego, California 92127, US
RABINOVICH, Aleksandr, K
La Jolla, California 92037, US
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.